Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-041137
Filing Date
2010-08-10
Accepted
2010-08-10 14:12:58
Documents
2
Period of Report
2010-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd283305.html 4  
1 FORM 4 rrd283305.xml 4 14070
2 EXHIBIT rrd253864_286593.htm EX-99.1 1141
  Complete submission text file 0001181431-10-041137.txt   17818
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Issuer) CIK: 0001356857 (see all company filings)

EIN.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 SAND HILL ROAD BUILDING 4, SUITE 210 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 4, SUITE 210 MENLO PARK CA 94025 650-233-2211
Versant Side Fund III, L.P. (Reporting) CIK: 0001456585 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 101004555

Mailing Address 3000 SAND HILL ROAD BUILDING 4, SUITE 210 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 4, SUITE 210 MENLO PARK CA 94025 650-233-2211
Versant Venture Capital III, L.P. (Reporting) CIK: 0001456586 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 101004556